Interactions between fentanyl and 2,5-dimethoxy-4-methylamphetamine: Ventilatory effects in nonhuman primates
1Department of Pharmacology and Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
The Journal of Pharmacology and Experimental Therapeutics
|September 28, 2025
Summary
The psychedelic 2,5-dimethoxy-4-methylamphetamine (DOM) worsened breathing problems caused by the opioid fentanyl in monkeys. This interaction increases overdose risks when combining these substances.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- Growing interest in psychedelic therapeutics necessitates understanding potential drug interactions.
- Opioid use, particularly with fentanyl, carries significant risks, including respiratory depression.
- Psychedelics are increasingly available, raising concerns about concurrent use with other substances.
Purpose of the Study:
- To investigate the interaction between 2,5-dimethoxy-4-methylamphetamine (DOM) and fentanyl.
- To determine if DOM affects fentanyl-induced respiratory depression in a preclinical model.
Main Methods:
- Rhesus monkeys (n=6) were administered fentanyl and DOM alone and in combination.
- Head plethysmography was used to measure ventilatory function (tidal volume).
- Dose-response relationships were assessed for each drug and their mixtures.
Main Results:
- Fentanyl alone caused a dose-dependent decrease in tidal volume.
- DOM alone did not significantly affect ventilation.
- Combining DOM with fentanyl resulted in greater ventilatory depression than fentanyl alone in most subjects.
Conclusions:
- 2,5-dimethoxy-4-methylamphetamine (DOM) may exacerbate opioid-induced respiratory depression.
- This interaction could increase the risk of overdose when psychedelics and opioids are co-administered.
- Further research is needed to determine if these findings apply to other opioid and psychedelic combinations.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
540
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
540
Opioid Analgesics: Synthetic and Semisynthetic Opioids
872
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
872


